• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑胶质瘤的外科治疗及进展。

Surgical Management and Advances in the Treatment of Glioma.

机构信息

Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.

出版信息

Semin Neurol. 2023 Dec;43(6):810-824. doi: 10.1055/s-0043-1776766. Epub 2023 Nov 14.

DOI:10.1055/s-0043-1776766
PMID:37963582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11229982/
Abstract

The care of patients with both high-grade glioma and low-grade glioma necessitates an interdisciplinary collaboration between neurosurgeons, neuro-oncologists, neurologists and other practitioners. In this review, we aim to detail the considerations, approaches and advances in the neurosurgical care of gliomas. We describe the impact of extent-of-resection in high-grade and low-grade glioma, with particular focus on primary and recurrent glioblastoma. We address advances in surgical methods and adjunct technologies such as intraoperative imaging and fluorescence guided surgery that maximize extent-of-resection while minimizing the potential for iatrogenic neurological deficits. Finally, we review surgically-mediated therapies other than resection and discuss the role of neurosurgery in emerging paradigm-shifts in inter-disciplinary glioma management such as serial tissue sampling and "window of opportunity trials".

摘要

高等级和低等级神经胶质瘤患者的护理需要神经外科医生、神经肿瘤学家、神经学家和其他从业者之间的跨学科合作。在这篇综述中,我们旨在详细介绍神经外科治疗神经胶质瘤的注意事项、方法和进展。我们描述了高等级和低等级神经胶质瘤切除范围的影响,特别关注原发性和复发性胶质母细胞瘤。我们讨论了最大限度地扩大切除范围同时最大限度地减少医源性神经功能缺损的潜在风险的手术方法和辅助技术的进展,如术中成像和荧光引导手术。最后,我们回顾了除切除以外的手术介导治疗方法,并讨论了神经外科在神经胶质瘤综合管理中出现的一些范式转变中的作用,如连续组织取样和“机会之窗试验”。

相似文献

1
Surgical Management and Advances in the Treatment of Glioma.脑胶质瘤的外科治疗及进展。
Semin Neurol. 2023 Dec;43(6):810-824. doi: 10.1055/s-0043-1776766. Epub 2023 Nov 14.
2
Intraoperative imaging technology to maximise extent of resection for glioma.术中成像技术以最大化胶质瘤的切除范围。
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD012788. doi: 10.1002/14651858.CD012788.pub2.
3
Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis.术中影像技术最大化脑胶质瘤切除术范围:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013630. doi: 10.1002/14651858.CD013630.pub2.
4
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.术中 5-ALA 荧光引导切除高级别胶质瘤可提高切除程度,改善预后:系统评价。
J Neurooncol. 2022 Jan;156(2):233-256. doi: 10.1007/s11060-021-03901-9. Epub 2022 Jan 6.
5
Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.5-氨基酮戊酸荧光引导切除联合光动力疗法治疗复发性脑胶质瘤的配对队列研究。
Acta Neurochir (Wien). 2024 May 13;166(1):212. doi: 10.1007/s00701-024-06108-9.
6
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.神经外科医生大会关于化疗在成人新诊断的世界卫生组织二级弥漫性胶质瘤中作用的系统评价和循证指南:更新版
J Neurooncol. 2025 Jan;171(2):279-298. doi: 10.1007/s11060-024-04861-6. Epub 2024 Nov 20.
7
The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.5-氨基酮戊酸在脑肿瘤手术中的作用:一项系统评价。
Neurosurg Rev. 2016 Oct;39(4):545-55. doi: 10.1007/s10143-015-0695-2. Epub 2016 Jan 27.
8
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
9
Insular Gliomas. Experience in a Latin American Center and Assessment of Variables Related to Surgical Management and Prognosis.岛叶胶质瘤。拉丁美洲一个中心的经验以及与手术治疗和预后相关变量的评估。
World Neurosurg. 2024 Nov;191:e652-e663. doi: 10.1016/j.wneu.2024.09.019. Epub 2024 Sep 10.
10
Biopsy versus resection for the management of low-grade gliomas.活检与手术切除用于低级别胶质瘤的治疗比较
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD009319. doi: 10.1002/14651858.CD009319.pub3.

引用本文的文献

1
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.胶质母细胞瘤的生存预测:来自荷兰神经外科质量登记处的10年随访
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080-3.
2
MiR-326: Role and significance in brain cancers.微小RNA-326:在脑癌中的作用及意义
Noncoding RNA Res. 2025 Feb 25;12:56-64. doi: 10.1016/j.ncrna.2025.02.006. eCollection 2025 Jun.
3
Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model.使用计算机模拟模型,活检部位和肿瘤相关巨噬细胞在预测恶性胶质瘤复发中的作用

本文引用的文献

1
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.纠正胶质母细胞瘤的药物开发模式需要进行系列组织采样。
Nat Med. 2023 Oct;29(10):2402-2405. doi: 10.1038/s41591-023-02464-8.
2
Diffusion tensor imaging versus intraoperative subcortical mapping for glioma resection: a systematic review and meta-analysis.弥散张量成像与术中皮质下定位在脑胶质瘤切除中的对比:系统评价和荟萃分析。
Neurosurg Rev. 2023 Jun 28;46(1):154. doi: 10.1007/s10143-023-02058-5.
3
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
NPJ Syst Biol Appl. 2025 Jan 8;11(1):3. doi: 10.1038/s41540-024-00478-7.
4
Gene Expression of /CD114 Is Associated with Poorer Patient Survival in Glioma.CD114 基因表达与胶质瘤患者生存状况较差相关。
Int J Mol Sci. 2024 Mar 5;25(5):3020. doi: 10.3390/ijms25053020.
术中磁共振引导切除并不优于 5-氨基酮戊酸引导在新诊断的胶质母细胞瘤:一项前瞻性对照多中心临床试验。
J Clin Oncol. 2023 Dec 20;41(36):5512-5523. doi: 10.1200/JCO.22.01862. Epub 2023 Jun 19.
4
Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging for Language Mapping in Brain Tumor Surgery: Validation With Direct Cortical Stimulation and Cortico-Cortical Evoked Potential.功能磁共振成像和弥散张量成像在脑肿瘤手术中的语言定位:直接皮层刺激和皮质-皮质诱发电位的验证。
Korean J Radiol. 2023 Jun;24(6):553-563. doi: 10.3348/kjr.2022.1001.
5
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.使用新的 RANO 切除范围分类对复发性胶质母细胞瘤再次切除的预后评估:来自 RANO 切除组的报告。
Neuro Oncol. 2023 Sep 5;25(9):1672-1685. doi: 10.1093/neuonc/noad074.
6
Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study.再次手术时机对复发性胶质母细胞瘤患者生存的影响:一项回顾性多中心描述性研究
Cancers (Basel). 2023 Apr 28;15(9):2530. doi: 10.3390/cancers15092530.
7
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.随机 III 期临床试验评估皮下利妥昔单抗作为低肿瘤负担滤泡性淋巴瘤的一线治疗:LYSA 研究结果。
J Clin Oncol. 2023 Jul 1;41(19):3523-3533. doi: 10.1200/JCO.22.02327. Epub 2023 Apr 18.
8
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.沃拉西尼布和伊沃西尼布治疗 IDH1 突变型低级别胶质瘤:一项随机、围手术期的 1 期临床试验。
Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23.
9
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study.替莫唑胺时代复发性胶质母细胞瘤的再次手术切除:一项真实世界的多中心研究。
Br J Neurosurg. 2024 Dec;38(6):1381-1389. doi: 10.1080/02688697.2023.2167931. Epub 2023 Jan 18.
10
Effect of Extent of Resection on Survival of Patients with Glioblastoma, IDH-Wild-Type, WHO Grade 4 (WHO 2021): Systematic Review and Meta-Analysis.胶质母细胞瘤、IDH 野生型、WHO 分级 4(WHO 2021)患者的生存与切除范围的关系:系统评价和荟萃分析。
World Neurosurg. 2023 Mar;171:e524-e532. doi: 10.1016/j.wneu.2022.12.052. Epub 2022 Dec 16.